Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: GSK's $2 Billion Acquisition of RAPT Therapeutics
In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of RAPT Therapeutics, Atkins…
4 months ago
Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma
In today’s Pharmaceutical Executive Daily, Henlius enters a global exclusive licensing agreement with UMAb Biopharma for a potential best-in-class an…
4 months ago
Pharmaceutical Executive Daily: President Trump's Great Healthcare Plan
In today’s Pharmaceutical Executive Daily, Johnson & Johnson announces plans for a second $2 billion manufacturing facility in North Carolina, Presid…
4 months ago
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
In today’s Pharmaceutical Executive Daily we will focus on the 44th Annual J.P. Morgan Healthcare Conference, with Genmab outlining a disciplined str…
4 months ago
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
In today’s Pharmaceutical Executive Daily we will focus on the 44th Annual J.P. Morgan Healthcare Conference, with Biogen outlining how a more focuse…
4 months ago
Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment
In today’s Pharmaceutical Executive Daily, Johnson & Johnson reaches an agreement with the Trump administration while continuing its $55 billion U.S.…
4 months, 1 week ago
Pharmaceutical Executive Daily: FDA Limits Regulations of Non-Medical Fitness Devices
In today’s Pharmaceutical Executive Daily, the FDA moves to limit regulation of non-medical fitness wearables, industry leaders examine how humans an…
4 months, 1 week ago
Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
4 months, 1 week ago
Pharmaceutical Executive Daily: Alnylam Invests $250 Million in Manufacturing Facility
In today’s Pharmaceutical Executive Daily, Eli Lilly and Nimbus Therapeutics announce a major licensing deal for oral obesity treatments, Hoth Therap…
4 months, 2 weeks ago
Pharmaceutical Executive Daily: Wegovy Pill Becomes Available
In today’s Pharmaceutical Executive Daily, the Wegovy Pill becomes the first available oral GLP-1 for weight management, clears a new therapy to prev…
4 months, 2 weeks ago